BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25189355)

  • 21. Organelle-Derived Acetyl-CoA Promotes Prostate Cancer Cell Survival, Migration, and Metastasis via Activation of Calmodulin Kinase II.
    Yu G; Cheng CJ; Lin SC; Lee YC; Frigo DE; Yu-Lee LY; Gallick GE; Titus MA; Nutt LK; Lin SH
    Cancer Res; 2018 May; 78(10):2490-2502. PubMed ID: 29535221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis.
    Jin JK; Tien PC; Cheng CJ; Song JH; Huang C; Lin SH; Gallick GE
    Oncogene; 2015 Apr; 34(14):1811-21. PubMed ID: 24793790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
    Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
    Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines.
    Zayzafoon M; Abdulkadir SA; McDonald JM
    J Biol Chem; 2004 Jan; 279(5):3662-70. PubMed ID: 14602722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer cells preferentially home to osteoblast-rich areas in the early stages of bone metastasis: evidence from in vivo models.
    Wang N; Docherty FE; Brown HK; Reeves KJ; Fowles AC; Ottewell PD; Dear TN; Holen I; Croucher PI; Eaton CL
    J Bone Miner Res; 2014 Dec; 29(12):2688-96. PubMed ID: 24956445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulation of cystathionine γ-lyase promotes prostate cancer progression and metastasis.
    Wang YH; Huang JT; Chen WL; Wang RH; Kao MC; Pan YR; Chan SH; Tsai KW; Kung HJ; Lin KT; Wang LH
    EMBO Rep; 2019 Oct; 20(10):e45986. PubMed ID: 31468690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of regulatory events associated with membrane targeting of p90 ribosomal S6 kinase 1.
    Richards SA; Dreisbach VC; Murphy LO; Blenis J
    Mol Cell Biol; 2001 Nov; 21(21):7470-80. PubMed ID: 11585927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate Cancer.
    Watanabe K; Hirata M; Tominari T; Matsumoto C; Fujita H; Yonekura K; Murphy G; Nagase H; Miyaura C; Inada M
    J Biol Chem; 2016 Sep; 291(40):20891-20899. PubMed ID: 27539855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis.
    Nandana S; Tripathi M; Duan P; Chu CY; Mishra R; Liu C; Jin R; Yamashita H; Zayzafoon M; Bhowmick NA; Zhau HE; Matusik RJ; Chung LW
    Cancer Res; 2017 Mar; 77(6):1331-1344. PubMed ID: 28108510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.
    Bhatia V; Saini MK; Shen X; Bi LX; Qiu S; Weigel NL; Falzon M
    Mol Cancer Ther; 2009 Jul; 8(7):1787-98. PubMed ID: 19584236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells.
    Zhang S; Wang Y; Chen S; Li J
    Biomed Pharmacother; 2018 Oct; 106():1396-1403. PubMed ID: 30119212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribosomal S6 kinase (RSK) regulates phosphorylation of filamin A on an important regulatory site.
    Woo MS; Ohta Y; Rabinovitz I; Stossel TP; Blenis J
    Mol Cell Biol; 2004 Apr; 24(7):3025-35. PubMed ID: 15024089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth.
    Yao K; Peng C; Zhang Y; Zykova TA; Lee MH; Lee SY; Rao E; Chen H; Ryu J; Wang L; Zhang Y; Gao G; He W; Ma WY; Liu K; Bode AM; Dong Z; Li B; Dong Z
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):12791-12796. PubMed ID: 29133416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.
    Li X; Sterling JA; Fan KH; Vessella RL; Shyr Y; Hayward SW; Matrisian LM; Bhowmick NA
    Mol Cancer Res; 2012 Apr; 10(4):494-503. PubMed ID: 22290877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining the role of the RSK isoforms in cancer.
    Houles T; Roux PP
    Semin Cancer Biol; 2018 Feb; 48():53-61. PubMed ID: 28476656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer.
    Wozniak DJ; Kajdacsy-Balla A; Macias V; Ball-Kell S; Zenner ML; Bie W; Tyner AL
    Nat Commun; 2017 Nov; 8(1):1508. PubMed ID: 29142193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The secreted matrix protein mindin increases prostate tumor progression and tumor-bone crosstalk via ERK 1/2 regulation.
    Ardura JA; Gutiérrez-Rojas I; Álvarez-Carrión L; Rodríguez-Ramos MR; Pozuelo JM; Alonso V
    Carcinogenesis; 2019 Jul; 40(7):828-839. PubMed ID: 31168562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
    Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
    Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer.
    Sawada Y; Kikugawa T; Iio H; Sakakibara I; Yoshida S; Ikedo A; Yanagihara Y; Saeki N; Győrffy B; Kishida T; Okubo Y; Nakamura Y; Miyagi Y; Saika T; Imai Y
    Int J Cancer; 2020 Mar; 146(5):1369-1382. PubMed ID: 31276604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo.
    Smith JA; Poteet-Smith CE; Malarkey K; Sturgill TW
    J Biol Chem; 1999 Jan; 274(5):2893-8. PubMed ID: 9915826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.